Role of the bethesda system in cervical cancer screening: A 5 year study
3rd Indo-Global Summit & Expo on Healthcare
October 05-07, 2015 New Delhi, India

Sadaf Haiyat, Kafil Akhtar, Rana K Sherwani, Shamshad Ahmad and Noora Sayeed

Jawaharlal Nehru Medical College- Aligarh, India

Scientific Tracks Abstracts: Health Care: Current Reviews


Cervical cancer is the second most common type of cancer among women worldwide. Exfoliative cytology remains the mainstay for screening of pre-cancerous lesions. A comparative study of conventional Pap smear with revised Bethesda system in the detection of cervical intra-epithelial neoplasia was done over a period of 5 years study in the Jawaharlal Nehru Medical College, Aligarh. Total of 318 premalignant lesions were noted, most commonly were in the fourth decade. Conventional system reported around 18.3% of premalignant lesions while it was 31.8% when reviewed by Bethesda system. The incidence of various pre-malignant lesions diagnosed were atypical squamous cells of undetermined significance (ASC-US) in 2.3% of cases, atypical squamous cells, cannot exclude HSIL (ASC-H) in 0.4%, low grade squamous intraepithelial lesions (LSIL) in 18.7%, high grade squamous intraepithelial lesions (HSIL) in 6%, atypical glandular cells of undetermined significance (AGUS) in 3.5% and atypical glandular cells favoring neoplasia in 0.9% cases. However, no premalignant glandular lesions were reported in conventional reporting of cervical cancer. The revised Bethesda system for cervical cancer has proven to be more valuable in detecting pre-malignant lesions especially glandular lesions which are usually missed on conventional reporting.

Biography :

Sadaf Haiyat is currently pursuing MD Pathology from Jawaharlal Nehru Medical College, Aligarh Muslim University, India. She has published 5 papers in reputed national and international journals.

Email: [email protected]